Primary Hepatocellular Carcinoma Clinical Trial
Official title:
Phase I/II Safety and Tolerability Study of the Monoclonal Antibody CT-011 in Patients With Hepatocellular Carcinoma
The objective of this pilot study is to evaluate the safety, tolerability and activity of the monoclonal antibody CT-011 administered intravenously to patients with Primary Hepatocellular Carcinoma.
n/a
Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03614546 -
Clinical Trial of Radiotherapy in Treating Primary Hepatocellular Carcinoma
|
N/A | |
| Not yet recruiting |
NCT03672305 -
Clinical Study on the Efficacy and Safety of c-Met/PD-L1 CAR-T Cell Injection in the Treatment of HCC
|
Early Phase 1 | |
| Not yet recruiting |
NCT06124001 -
Clinical Study of VG161 Combined With Camrelizumab in Patients With Advanced Primary Hepatocellular Carcinoma
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT02956772 -
Transcatheter Arterial Chemoembolization (TACE) in Combination With Arsenic Trioxide Versus TACE in the Treatment of Middle-advanced Primary Hepatocellular Carcinoma (HCC) Patients
|
Phase 2 | |
| Active, not recruiting |
NCT01563484 -
Comparison of Liver and Renal Function After Transarterial Chemoembolization for Primary Hepatocellular Carcinoma With Iso-osmolar Contrast Media and Low Osmolar Contrast Media
|
Phase 2/Phase 3 | |
| Not yet recruiting |
NCT05872841 -
H101 Combined With TACE for Primary Hepatocellular Carcinoma With Portal Vein Thrombosis
|
Phase 2 | |
| Recruiting |
NCT05242757 -
Clinical Study of MAK Immune Cells in the Treatment of PHC
|
N/A | |
| Completed |
NCT01828762 -
Autologous Immune Cell Therapy in Primary Hepatocellular Carcinoma Patients Following Resection and TACE Therapy
|
N/A |